Trial Profile
Safety,Tolerability, and Pharmacokinetics of 3 g of Ceftolozane/Tazobactam in Healthy Adults:A Randomized, Placebo-Controlled, Multiple-Dose Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 May 2018
Price :
$35
*
At a glance
- Drugs Ceftolozane/tazobactam (Primary)
- Indications Gram-negative infections; Intra-abdominal infections; Nosocomial pneumonia; Pyelonephritis; Urinary tract infections
- Focus Adverse reactions; Pharmacokinetics
- 24 May 2018 New trial record
- 01 May 2018 Results published in the Clinical Pharmacology in Drug Development